News | December 17, 2023
Dr. Reddy's becomes first Indian pharma company to debut on the DJSI
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
This surgery presented unique challenges, particularly due to the size of the gallbladder and the multitude of stones
Subscribe To Our Newsletter & Stay Updated
